{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Atlanta&page=12&state=Georgia", "query": { "state": "Georgia", "city": "Atlanta", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 13063, "total_pages": 1307, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Atlanta&page=13&state=Georgia&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Atlanta&page=11&state=Georgia&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-03T18:11:06.391Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01146600", "title": "Clarithromycin for the Treatment of Hypersomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypersomnia", "Idiopathic Hypersomnia", "Narcolepsy" ], "interventions": [ { "name": "Clarithromycin followed by placebo", "type": "DRUG" }, { "name": "Placebo then Clarithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lynn Marie Trotti", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2010-07", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2017-11-06", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01146600" }, { "nct_id": "NCT02074436", "title": "PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hematological Malignancies", "Thrombocytopenia" ], "interventions": [ { "name": "EACA", "type": "DRUG" }, { "name": "Platelet transfusion", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 29, "start_date": "2014-05-23", "completion_date": "2021-05-14", "has_results": true, "last_update_posted_date": "2022-07-19", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Decatur, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02074436" }, { "nct_id": "NCT06765109", "title": "Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-small Cell Lung Cancer", "Anaplastic Lymphoma Kinase-positive" ], "interventions": [ { "name": "Neladalkib (NVL-655)", "type": "DRUG" }, { "name": "Alectinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nuvalent Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2025-07-17", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 23, "location_summary": "Glendale, Arizona • Newport Beach, California • Orange, California + 19 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06765109" }, { "nct_id": "NCT01886872", "title": "Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Stage I Chronic Lymphocytic Leukemia", "Stage II Chronic Lymphocytic Leukemia", "Stage III Chronic Lymphocytic Leukemia", "Stage IV Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "Bendamustine Hydrochloride", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Ibrutinib", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Rituximab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 547, "start_date": "2014-01-15", "completion_date": "2027-06-24", "has_results": true, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 917, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 596 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01886872" }, { "nct_id": "NCT00151528", "title": "An Open-Label Trial of Pregabalin in Patients With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 428, "start_date": "2005-01", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 93, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00151528" }, { "nct_id": "NCT02844465", "title": "Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Temporal Lobe Epilepsy" ], "interventions": [ { "name": "Visualase MRI-Guided Laser Ablation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "MedtronicNeuro", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 167, "start_date": "2016-12", "completion_date": "2023-12-11", "has_results": true, "last_update_posted_date": "2025-01-17", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 23, "location_summary": "Newport Beach, California • Palo Alto, California • San Francisco, California + 20 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02844465" }, { "nct_id": "NCT05242471", "title": "A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Guselkumab", "type": "BIOLOGICAL" }, { "name": "Golimumab", "type": "BIOLOGICAL" }, { "name": "JNJ-78934804", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 703, "start_date": "2022-07-22", "completion_date": "2029-11-05", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 90, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Apple Valley", "state": "California" }, { "city": "Arcadia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05242471" }, { "nct_id": "NCT01787409", "title": "Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aggressive Non-Hodgkin Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Enteropathy-Associated T-Cell Lymphoma", "Hepatosplenic T-Cell Lymphoma", "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Mediastinal (Thymic) Large B-Cell Lymphoma", "Nasal Type Extranodal NK/T-Cell Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Primary Cutaneous Anaplastic Large Cell Lymphoma", "Refractory Anaplastic Large Cell Lymphoma", "Small Lymphocytic Lymphoma", "Subcutaneous Panniculitis-Like T-Cell Lymphoma" ], "interventions": [ { "name": "Cholecalciferol", "type": "DIETARY_SUPPLEMENT" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 565, "start_date": "2013-03-06", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-06-16", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 5, "location_summary": "Scottsdale, Arizona • Atlanta, Georgia • Iowa City, Iowa + 2 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01787409" }, { "nct_id": "NCT02727699", "title": "A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dementia, Alzheimer Type" ], "interventions": [ { "name": "Xanamem™", "type": "DRUG" }, { "name": "Placebo (for Xanamem™)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actinogen Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 185, "start_date": "2017-03-23", "completion_date": "2019-03-15", "has_results": true, "last_update_posted_date": "2025-02-03", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 14, "location_summary": "Tucson, Arizona • Los Angeles, California • Poway, California + 11 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02727699" }, { "nct_id": "NCT00048022", "title": "Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dual Integrin Antagonist", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": null, "start_date": "2002-10-25", "completion_date": "2004-02-02", "has_results": false, "last_update_posted_date": "2017-06-19", "last_synced_at": "2026-11-03T18:11:06.391Z", "location_count": 59, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 50 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048022" } ] }